Introduction: Pericardial effusion (PE) is a complication of late-stage cancer and some patients never leave the hospital despite drainage. The main objective of this study was to identify predictors of hospital discharge in cancer patients with (PE) who underwent pericardial drainage. We also report the occurrence of paradoxical hemodynamic instability (PHI).
Methods and Materials:
A retrospective study was carried out in a cancer center.
Patients included had malignancy, PE, and underwent surgical drainage. An institutional database was reviewed for preoperative variables, analyzed for hospital discharge.
Results: One-hundred and thirteen patients were included, with a mean age of 54 years old (SD 14.3). Sixty-three patients were discharged from hospital (55.7%). Age (odds ratio [OR], 1.04; P = 0.004), higher ECOG status (OR, 0.63; P = 0.019), recent chemotherapy (OR, 3.40; P = 0.007), and renal failure (OR, 0.14; P = 0.002) were associated with hospital discharge. Median survival was 43 days (IQ 25%-75%; 15-162). Patients with pulmonary embolism or neutropenia were at greater risk of developing PHI (OR, 10.11; P = 0.009 and OR, 12.13; P = 0.015, respectively).
Conclusion: Almost half of the patients never left the hospital. Patients with no chemotherapy within 45 days of procedure, patients with renal failure and higher ECOG status are at greater risk of not getting discharged. PHI remains a serious condition with high mortality.
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hospital discharge, malignant pericardial effusion, paradoxical hemodynamic instability (PHI), pericardial drainage, pericardial effusion (PE) of the risks is paradoxical hemodynamic instability (PHI), a condition in which patients, despite pericardial drainage, course with severe hypotension and shock unresponsive to vasopressors with no identifiable causes other than the surgical procedure itself. 3, 9 Thus, surgeons must be certain that surgical drainage will be beneficial, despite its risks. Previous studies have addressed prognostic factors, survival, and have compared different surgical approaches. Nevertheless, they did not address predictors of hospital discharge. [1] [2] [3] 6, 8, [10] [11] [12] This is very relevant because it involves expenses in health care and patient's quality-of-life. Therefore, the objective of this study was to evaluate clinical and radiologic features that could predict hospital discharge of oncologic patients who underwent surgical pericardial drainage. As secondary outcomes, we looked at predictors of discharge from intensive care unit (ICU), 30-day postoperative mortality and the occurrence of PHI.
| MATERIALS AND METHODS
We retrospectively reviewed the records of patients with PE who underwent surgical intervention in a tertiary cancer-care center 
| Study population
All patients with malignant disease and symptomatic PE that required drainage in our institution during the study period were included. We excluded patients who had undergone, on a different occasion, previous pericardial drainage (recurrent effusion) and patients who underwent pericardiocentesis only. 
| Interventions
The decision to perform a surgical intervention was based on either Follow-up included a postoperative consultation 1 month after surgery and each 3 months thereafter. If patients did not attend a consultation with either the oncologist or the thoracic surgeon, they were reached by phone contact. Patients that remained in-hospital were followed daily until discharge or death. Overall survival, hospital, and ICU discharge and date of death were measured in days from baseline (surgery) to the date of the occurrence or the last follow-up (July 2015).
| Data collection and definition of outcomes

| Statistical analysis
Categorical variables are presented as absolute numbers and percentage. Continuous variables are presented as mean and standard deviation when they had normal distribution or as median and interquartile interval when they had an asymmetric distribution.
Kaplan-Meier curves were applied for survival. Stepwise logistic regression was used to identify predictors for hospital and ICU discharge and for the occurrence of PHI. Cox-regression was used to identify predictors of survival. P was considered statistically significant if less than 0.05. Statistics were performed using Stata 13 (StataCorp).
| RESULTS
Between January 2011 and January 2015, 122 individuals with malignant disease who developed PE were treated at our institution. Six patients had previously undergone pericardial drainage and three were treated with pericardiocentesis, therefore such patients were excluded, leaving 113 in the final analysis. Baseline demographics are available in Table 1 .
There were 59 women (52.2%) and 54 men (47.8% 
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Two patients suffered intraoperative hemorrhage: one due to myocardial injury, controlled after suture through left thoracotomy and another patient possessed a vena cava filter which migrated and caused multiple myocardial perforations and massive fatal bleeding despite attempt to suture. Intra and postoperative results are summarized in Table 2 .
On multivariate analysis, hospital discharge was negatively influenced by ECOG status (OR, 0.63; P = 0.019) and renal failure (OR, 0.14; P = 0.002). Older age (OR, 1.04; P = 0.004) and chemotherapy within 45 days of the procedure (OR, 3.40; P = 0.007) increased the odds of hospital discharge. ICU discharge was also significantly influenced by age (OR, 1.04; P = 0.004), recent chemotherapy (OR, 2.61; P = 0.033), and acute renal failure (OR, 0.14; P = 0.001), as Table   3 demonstrates.
Finally, PHI was more likely to occur in patients with pulmonary embolism (OR, 10.11; P = 0.009) and neutropenia (OR, 12.13; P = 0.015).
The 30-day mortality associated with PHI was more than twice higher than the rate for patients who did not develop it (87.5% vs 40.9%; P < 0.001).
| DISCUSSION
In the current study, we evaluated patients with cancer and PE that required surgical drainage. Most of them were symptomatic and presented with either cardiac tamponade or diastolic restriction and right ventricle collapse on echocardiogram. Almost half of our patients (44.3%) did not leave the hospital despite surgical drainage confirming the severity of such a condition and the need of predictors to better select patients for invasive procedures and to avoid futile interventions. In our cohort, patients with higher ECOG scores, renal failure, with no chemotherapy within 45 days of procedure and younger age were more likely to die in the hospital.
The severity of malignant pericardial effusion is evident with low survival reported by many authors. Studies with cancer patients and PE report median survival ranging from 112 days to 5 months. [1] [2] [3] 5 Our median survival was 43 days, lower than previously reported, but some characteristics of our patients could explain this finding. Most of our patients had lung cancer and more than 70% had a diastolic restriction on echocardiogram, both characteristics are associated with poor survival. 4, 10 Better survival was found in studies that did not enroll oncologic patients exclusively. 8, 10, 12 We identified four variables independently associated with hospital discharge in our cohort of patients. Two of them, with high ECOG score and no recent chemotherapy, are directly related to a more advanced status of the baseline disease. Therefore, patients in overwhelming the right ventricle. 13 Another possibility is that during tamponade the coronary flow diminishes, resulting in impaired contractility and systolic function that goes on even after the fluid is released. 3, 14 It was observed in 7% of our cases. Previous papers have conflicting results regarding its etiology, physiopathology, and incidence, with the latter varying from 5% to as high as 87.5%. 3, 5, 9 This large difference might be a result of varied criteria to its occurrence. All the patients who developed PHI in our cohort died and this condition was associated with pulmonary embolism and neutropenia.
The main weakness of this study is its retrospective nature.
Nonetheless, all our data were collected from a prospectively filled electronic database. Thus, the information is reliable and, more importantly, we had no missing data concerning preoperative features. In addition, this is a single center study, however the broad inclusion criteria make our results generalizable to other cancer centers. This study contains one of the largest number of patients (113) in the literature when considering the occurrence of PE in the cancer population, but it still constitutes a small sample size.
| CONCLUSION
PE is a serious and life-threatening condition in patients with cancer, and it deeply impairs their quality of life. Life expectancy is poor and futile procedures should be avoided. Individuals with higher ECOG status and renal failure have lower chances of ever getting out of the hospital. Our data are not enough to support that surgery should not be performed on these patients, but it indicates that it should be carefully indicated after throughout discussion with multidisciplinary teams and patients' families.
On the other hand, patients treated with chemotherapy within 45 days before the procedure are more likely to leave the ICU and the hospital.
PHI severely increases the risk of death-the reason why patients should be carefully monitored after pericardial drainage-and it appears to occur in the setting of neutropenia and pulmonary embolism.
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